A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

Clicks: 262
ID: 270448
1996
Article Quality & Performance Metrics
Overall Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
The adenoviral oncoprotein E1A induces progression through the cell cycle by binding to the products of the p300/CBP and retinoblastoma gene families. A new cellular p300/CBP-associated factor (P/CAF) having intrinsic histone acetylase activity has been identified that competes with E1A. Exogenous e …
Reference Key
xj1996naturea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yang XJ;Ogryzko VV;Nishikawa J;Howard BH;Nakatani Y;;
Journal Nature
Year 1996
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8684459
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Molecular humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't amino acid sequence Nuclear Proteins / metabolism* Transcription Factors / metabolism* Molecular Sequence Data recombinant fusion proteins / genetics cell cycle cloning hela cells protein binding cell cycle proteins / genetics cell cycle proteins / metabolism* recombinant fusion proteins / metabolism sequence deletion escherichia coli histone acetyltransferases trans-activators* saccharomyces cerevisiae proteins* acetyltransferases / genetics p300-cbp transcription factors adenovirus e1a proteins / metabolism* binding competitive pmid:8684459 doi:10.1038/382319a0 x j yang v v ogryzko y nakatani acetyltransferases / metabolism

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.